AACR International Conference on New Frontiers in Cancer Research

January 18-22, 2017
The Westin Cape Town
Cape Town, South Africa

Conference Cochairs
Peter A. Jones, Van Andel Research Institute, Grand Rapids, Michigan, USA
Frank McCormick, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA

Program Committee
Lucile L. Adams-Campbell
, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA
Peter W. Atadja
, University of Health and Allied Sciences, Ho, Volta, Ghana
John D. Carpten
, USC Keck School of Medicine, Los Angeles, California, USA
Raymond N. DuBois
, Medical University of South Carolina, Charleston, South Carolina, USA
Richard M. Marais, Cancer Research UK Manchester Institute, Manchester, England
Jennifer Moodley
, University of Cape Town, Cape Town, South Africa
Olufunmilayo I. Olopade
, University of Chicago Medical Center, Chicago, Illinois, USA
Feyruz V. Rassool
, University of Maryland School of Medicine, Baltimore, Maryland, USA
Antoni Ribas
, UCLA Medical Center, Los Angeles, California, USA

  • Watch this message from Conference Co-chairperson Peter A. Jones:


This innovative program will bring the forefront of cancer science to Africa and will appeal to a broad spectrum of cancer researchers—from laboratory scientists to physicians in all disciplines of the cancer field. As part of AACR’s international efforts; the meeting will feature talks from leading basic, translational, and clinical researchers across the hottest areas in cancer research. The program will also feature several sessions dedicated to cancers that have a high rate of incidence in Africa and supplement international speakers with experts throughout the region. We anticipate that this meeting will be historic in its impact and will attract 300 attendees – most of who will be working from Africa or have collaborations/connections to research being conducted in Africa. In addition to the disease sites of particular interest to local researchers and clinicians, the program will feature sessions on DNA repair, epigenetics, genomic medicine, immunotherapy, molecular targets, prevention, and viruses and cancer.